Fol. Biol. 2025, 71, 88-94
Semi-automated RNA Isolation from Tempus Blood RNA Tubes Using the Magcore Plus II Instrument
High-throughput, precise and cost-effective isolation of high-quality RNA is essential for the growing number of RNA-based next-generation sequencing (NGS) analyses. Manual RNA isolation provides sufficient quality but requires significant hands-on time and carries an increased risk of contamination and sample misidentification. Here we describe a semi-automated protocol for the isolation of high-quality total RNA from 3 ml of peripheral blood collected in Tempus Blood RNA Tubes. The isolation can be performed either from the total volume of 9 ml of Tempus blood lysate or from smaller volumes (6 and 3 ml, respectively) using the MagCore triXact RNA Kit on the MagCore Plus II automated nucleic acid extractor, which allows RNA isolation in single tubes. The original isolation protocol (#631) for whole blood RNA isolation was customized by the manufacturer (#631T) by omitting the cell lysis step. After optimizing the process, we compared the yield and quality of 760 RNA samples isolated manually or by semi-automated methods. We conclude that RNA isolation using the semi-automated MagCore protocol yields 5-10 μg of total RNA from 6 ml of lysate (2 ml of peripheral blood), which is almost comparable in quantity and quality to manual isolation. In addition, we show that the remaining 3 ml of lysate is sufficient for backup re-isolation. Our semi-automated RNA protocol reduces hands-on time without increasing costs and yields bulky total RNA of a quality suitable for subsequent RNA NGS applications.
Keywords
total RNA isolation, semi-automated isolation, Tempus Blood RNA, MagCore triXact RNA Kit, next-generation sequencing (NGS).
Funding
This study has been supported by the by the Ministry of Health of the Czech Republic grant projects (NU23-03-00150 and RVO-VFN 64165); Charles University: COOPERATIO, SVV260631; UNCE/24/MED/022; the Ministry of Education, Youth and Sports of the Czech Republic: Programme EXCELES, ID Project No. LX22N-PO5104 – Funded by the European Union – Next Generation EU, and The National Center for Medical Genomics (LM2023067).
References
Copyright
This is an open-access article distributed under the terms of the Creative Commons Attribution License.